The public outcry against the Serum Institute has not only led to legal actions but also sparked a broader dialogue around vaccine equity, ethics in pharmaceutical manufacturing, and corporate responsibility. Advocacy groups have emerged, demanding transparency and the establishment of stringent safety measures in vaccine manufacturing. These groups underline the importance of informed consent and equitable health access in the larger framework of public health security.
Social media platforms have played a crucial role in shaping public discourse, with many users sharing personal stories and calling for accountability.
Adar Poonawalla & Serum Institute have been ordered to face prosecution in a Rs 10,000 Crores defamation suit filed by Awaken India Movement member Sh. Prakash Pohare. The Serum Company, which makes the Covishield vaccine, will have all its directors and employees facing accusations as well. The court can grant a decree of Rs. 10,000 Crores to be paid by the Serum Company, Adar and Cyrus Poonawallas to the plaintiff. The Awaken India Movement, a well-known NGO, has been campaigning against vaccine fraud since lockdown and has gained mass support from crores of people. The Adar Poonawalla and Serum Institute allegedly conspired to defame the Awaken India Movement and its members.
Mainstream media has long been criticized for its inadequate fact-checking and verification processes, particularly in relation to highly significant public health issues. Instead of adhering to journalistic integrity by thoroughly investigating claims and evidence, these media outlets have seemingly favored the narratives presented by individuals involved in controversial subjects, including the tragic fatalities associated with the widely distributed COVID-19 vaccines. Many people are starting to question whether vaccine companies, like Adar Poonawalla and the Serum Institute of India, are accountable for what they do. This is especially true because there have been many reports claiming that their products have caused deaths and other serious problems.
As concerns mount, citizens are increasingly questioning whether legal action will be taken against Poonawalla and the Serum Institute for their roles in these incidents. Will the courts be proactive in holding them responsible for the lives lost, or will there be an thorough investigation into the extensive documentation of adverse effects associated with their vaccines? The grave implications of these issues have cast a spotlight on both Adar Poonawalla and his organization, with both of them now facing intense scrutiny from the public and the media alike.
In recent developments, the High Court has placed a stay on any prosecution or jail time for Poonawalla and the Serum Institute until August 19th. The Poonawallas have taken to the High Court to challenge a previous order issued by a Senior Division Judge in Nagpur on August 2, 2024, which mandated prosecution under several sections of the Indian Penal Code (IPC), including but not limited to sections 181, 182, 193, 196, 198, 200, 465, 471, 474, 120(B), and 34. These sections pertain to offenses such as perjury, forgery, and conspiracy, underscoring the serious nature of the charges they face.
The High Court has expressed serious concerns regarding the conduct of the Poonawallas and the Serum Institute, finding them guilty of committing fraud upon the court. The court accused them of deliberately suppressing and manipulating critical information, as well as submitting false affidavits regarding the safety of the Covishield vaccine while denying the occurrence of side effects and fatalities associated with its use.
The ongoing story about Adar Poonawalla and the Serum Institute shows bigger problems in public health discussions, the media, and the justice system. People want answers and accountability, so it’s up to the courts and the media to uncover the real story about the COVID-19 vaccine injuries. This situation emphasizes how important fair journalism and unbiased legal checks are in protecting public health and trust.
As the upcoming hearing on August 19 approaches, the court is tasked with a significant decision: whether the Poonawallas should be allowed to make their case in the High Court, or if they should instead be directed to present their arguments at the District Court level. The outcome of this decision could have far-reaching implications for accountability in the public health sector and may set a precedent for how similar cases are handled in the future.
Source: Twitter-Image
Also Read: